Institution
University of East Anglia
Education•Norwich, Norfolk, United Kingdom•
About: University of East Anglia is a education organization based out in Norwich, Norfolk, United Kingdom. It is known for research contribution in the topics: Population & Climate change. The organization has 13250 authors who have published 37504 publications receiving 1669060 citations. The organization is also known as: UEA.
Papers published on a yearly basis
Papers
More filters
••
University of Freiburg1, University Medical Center Groningen2, Wellcome Trust3, European Centre for Disease Prevention and Control4, Imperial College London5, Spanish National Research Council6, Karolinska Institutet7, Karolinska University Hospital8, Université catholique de Louvain9, University of East Anglia10, Public Health England11, University of Fribourg12, University of Paris-Sud13, University of Siena14, University of Cologne15, Cardiff University16
TL;DR: The development of a consistent sampling framework and the results of the first structured survey on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals are reported.
Abstract: Summary Background Gaps in the diagnostic capacity and heterogeneity of national surveillance and reporting standards in Europe make it difficult to contain carbapenemase-producing Enterobacteriaceae. We report the development of a consistent sampling framework and the results of the first structured survey on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals. Methods National expert laboratories recruited hospitals with diagnostic capacities, who collected the first ten carbapenem non-susceptible clinical isolates of K pneumoniae or E coli and ten susceptible same-species comparator isolates and pertinent patient and hospital information. Isolates and data were relayed back to national expert laboratories, which made laboratory-substantiated information available for central analysis. Findings Between Nov 1, 2013, and April 30, 2014, 455 sentinel hospitals in 36 countries submitted 2703 clinical isolates (2301 [85%] K pneumoniae and 402 (15%) E coli ). 850 (37%) of 2301 K pneumoniae samples and 77 (19%) of 402 E coli samples were carbapenemase (KPC, NDM, OXA-48-like, or VIM) producers. The ratio of K pneumoniae to E coli was 11:1. 1·3 patients per 10 000 hospital admissions had positive clinical specimens. Prevalence differed greatly, with the highest rates in Mediterranean and Balkan countries. Carbapenemase-producing K pneumoniae isolates showed high resistance to last-line antibiotics. Interpretation This initiative shows an encouraging commitment by all participants, and suggests that challenges in the establishment of a continent-wide enhanced sentinel surveillance for carbapenemase-producing Enterobacteriaeceae can be overcome. Strengthening infection control efforts in hospitals is crucial for controlling spread through local and national health care networks. Funding European Centre for Disease Prevention and Control.
467 citations
••
TL;DR: Data are reported from a whole-ecosystem test of the iron-limitation hypothesis in the Southern Ocean, which show that surface uptake of atmospheric CO 2 and uptake ratios of silica to carbon by phytoplankton were strongly influenced by nanomolar increases of iron concentration.
Abstract: Photosynthesis by marine phytoplankton in the Southern Ocean, and the associated uptake of carbon, is thought to be currently limited by the availability of iron1,2. One implication of this limitation is that a larger iron supply to the region in glacial times3 could have stimulated algal photosynthesis, leading to lower concentrations of atmospheric CO2. Similarly, it has been proposed that artificial iron fertilization of the oceans might increase future carbon sequestration. Here we report data from a whole-ecosystem test of the iron-limitation hypothesis in the Southern Ocean4, which show that surface uptake of atmospheric CO2 and uptake ratios of silica to carbon by phytoplankton were strongly influenced by nanomolar increases of iron concentration. We use these results to inform a model of global carbon and ocean nutrients, forced with atmospheric iron fluxes to the region derived from the Vostok3 ice-core dust record. During glacial periods, predicted magnitudes and timings of atmospheric CO2 changes match ice-core records well. At glacial terminations, the model suggests that forcing of Southern Ocean biota by iron caused the initial ∼40 p.p.m. of glacial–interglacial CO2 change, but other mechanisms must have accounted for the remaining 40 p.p.m. increase. The experiment also confirms that modest sequestration of atmospheric CO2 by artificial additions of iron to the Southern Ocean is in principle possible, although the period and geographical extent over which sequestration would be effective remain poorly known.
467 citations
••
TL;DR: The current understanding of the process by which N(2)O is produced and destroyed is reviewed and the potential for feeding this into new approaches for combating N( 2)O release is discussed.
466 citations
••
TL;DR: Empirical emphasis is given to ecosystems dominated by the globally relevant haptophytes Emiliania huxleyi and Phaeocystis sp.
Abstract: Seawater concentrations of the climate-cooling, volatile sulphur compound dimethylsulphide (DMS) are the result of numerous production and consumption processes within the marine ecosystem. Due to this complex nature, it is difficult to predict temporal and geographical distribution patterns of DMS concentrations and the inclusion of DMS into global ocean climate models has only been attempted recently. Comparisons between individual model predictions, and ground-truthing exercises revealed that information on the functional relationships between physical and chemical ecosystem parameters, biological productivity and the production and consumption of DMS and its precursor dimethylsulphoniopropionate (DMSP) is necessary to further refine future climate models. In this review an attempt is made to quantify these functional relationships. The description of processes includes: (1) parameters controlling DMSP production such as species composition and abiotic factors; (2) the conversion of DMSP to DMS by algal and bacterial enzymes; (3) the fate of DMSP-sulphur due to, e.g., grazing, microbial consumption and sedimentation and (4) factors controlling DMS removal from the water column such as microbial consumption, photo-oxidation and emission to the atmosphere. We recommend the differentiation of six phytoplankton groups for inclusion in future models: eukaryotic and prokaryotic picoplankton, diatoms, dinoflagellates, and other phytoflagellates with and without DMSP-lyase activity. These functional groups are characterised by their cell size, DMSP content, DMSP-lyase activity and interactions with herbivorous grazers. In this review, emphasis is given to ecosystems dominated by the globally relevant haptophytes Emiliania huxleyi and Phaeocystis sp., which are important DMS and DMSP producers.
466 citations
••
TL;DR: Recent findings on the bioavailability and biological activity of (poly)phenols are summarized, focusing on the epidemiological and clinical evidence of beneficial effects of flavonoids and related compounds on urinary tract infections, cognitive function and age-related cognitive decline, cancer and cardiovascular disease.
Abstract: There is substantial interest in the role of plant secondary metabolites as protective dietary agents. In particular, the involvement of flavonoids and related compounds has become a major topic in human nutrition research. Evidence from epidemiological and human intervention studies is emerging regarding the protective effects of various (poly)phenol-rich foods against several chronic diseases, including neurodegeneration, cancer and cardiovascular diseases. In recent years, the use of HPLC-MS for the analysis of flavonoids and related compounds in foods and biological samples has significantly enhanced our understanding of (poly)phenol bioavailability. These advancements have also led to improvements in the available food composition and metabolomic databases, and consequently in the development of biomarkers of (poly)phenol intake to use in epidemiological studies. Efforts to create adequate standardised materials and well-matched controls to use in randomised controlled trials have also improved the quality of the available data. In vitro investigations using physiologically achievable concentrations of (poly)phenol metabolites and catabolites with appropriate model test systems have provided new and interesting insights on potential mechanisms of actions. This article will summarise recent findings on the bioavailability and biological activity of (poly)phenols, focusing on the epidemiological and clinical evidence of beneficial effects of flavonoids and related compounds on urinary tract infections, cognitive function and age-related cognitive decline, cancer and cardiovascular disease.
466 citations
Authors
Showing all 13512 results
Name | H-index | Papers | Citations |
---|---|---|---|
George Davey Smith | 224 | 2540 | 248373 |
Nicholas J. Wareham | 212 | 1657 | 204896 |
Cyrus Cooper | 204 | 1869 | 206782 |
Kay-Tee Khaw | 174 | 1389 | 138782 |
Phillip A. Sharp | 172 | 614 | 117126 |
Rory Collins | 162 | 489 | 193407 |
William J. Sutherland | 148 | 966 | 94423 |
Shah Ebrahim | 146 | 733 | 96807 |
Kenneth M. Yamada | 139 | 446 | 72136 |
Martin McKee | 138 | 1732 | 125972 |
David Price | 138 | 1687 | 93535 |
Sheila Bingham | 136 | 519 | 67332 |
Philip Jones | 135 | 644 | 90838 |
Peter M. Rothwell | 134 | 779 | 67382 |
Ivan Reid | 131 | 1318 | 85123 |